Hillsdale Investment Management »

Protalix Biotherapeutics shares owned by Hillsdale Investment Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Hillsdale Investment Management from 13F filings

Historical chart of Hillsdale Investment Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Hillsdale Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Hillsdale Investment Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $433k 186k 2.33
2025-06-30 $175k 118k 1.48
2025-03-31 $297k 116k 2.56